CABA
Cabaletta BioBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
CABA vs peer average
72/100
CABA vs. peer average (B vs. C)
Grade spread
A 1 · B 2 · C 3 · F 4
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
RNAC is the first available peer comparator.
Autoimmune cell-therapy development comparator, but its mRNA construct and dosing approach limit direct valuation transfer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CABA
Cabaletta Bio
RNAC
Cartesian Therapeutics
Grade
B
C
Momentum
64
13
Value
41
41
Sentiment
73
69
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs RNAC
CABA / RNAC
Grade Position
Above peers
CABA vs. peer average (B vs. C)
72/100
Momentum
64
CABAValue
41
CABASentiment
73
CABARotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CABA
RNAC is the first peer returned for this comparison set.